Skip to content
PubMed This is a summary of 39 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 39 referenced papers

Top Authors

Peter Bede
Trinity College Dublin
Gen Sobue
Nagoya University
Orla Hardiman
Trinity College Dublin
Giorgia Querin
Institut de Myologie
Angelo Poletti
University of Milan
Gianni Sorarú
University of Padua
Kenneth H. Fischbeck
University of Pennsylvania
Christopher Grunseich
Neuroscience Institute
Maria Pennuto
Veneto Institute of Molecular Medicine
Masahisa Katsuno
Nagoya University

Top Institutions

Ranked by publications Top 10 institutions

References

References (39)
  1. 1

    210th ENMC International Workshop: Research and clinical management of patients with spinal and bulbar muscular atrophy, 27-29 March, 2015, Naarden, The Netherlands.

    Pennuto M, Greensmith L, Pradat PF, et al.

    Neuromuscular disorders : NMD 2015; (25(10)):802-12.

    PMID: 26206601
  2. 2

    Non-neural phenotype of spinal and bulbar muscular atrophy: results from a large cohort of Italian patients.

    Querin G, Bertolin C, Da Re E, et al.

    Journal of neurology, neurosurgery, and psychiatry 2016; (87(8)):810-6 doi:10.1136/jnnp-2015-311305.

    PMID: 26503015
  3. 3

    Spinal and Bulbar Muscular Atrophy.

    Grunseich C, Fischbeck KH

    Neurologic clinics 2015; (33(4)):847-54.

    PMID: 26515625
  4. 4

    Spinal and Bulbar Muscular Atrophy Overview.

    Fischbeck KH

    Journal of molecular neuroscience : MN 2016; (58(3)):317-20 doi:10.1007/s12031-015-0674-7.

    PMID: 26547319
  5. 5

    Differences in F-Wave Characteristics between Spinobulbar Muscular Atrophy and Amyotrophic Lateral Sclerosis.

    Fang J, Cui L, Liu M, et al.

    Frontiers in aging neuroscience 2016; (8()):50 doi:10.3389/fnagi.2016.00050.

    PMID: 27014057
  6. 6

    Validation of the Italian version of the SBMA Functional Rating Scale as outcome measure.

    Querin G, DaRe E, Martinelli I, et al.

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2016; (37(11)):1815-1821 doi:10.1007/s10072-016-2666-y.

    PMID: 27444956
  7. 7

    [Clinical features of a genetically identified spinal and 
bulbar muscular atrophy pedigree].

    Wang Z, Chen Q, Li Q, Bi F

    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 2016; (41(10)):1101-1105 doi:10.11817/j.issn.1672-7347.2016.10.015.

    PMID: 27807335
  8. 8

    Correlation of insulin resistance and motor function in spinal and bulbar muscular atrophy.

    Nakatsuji H, Araki A, Hashizume A, et al.

    Journal of neurology 2017; (264(5)):839-847 doi:10.1007/s00415-017-8405-3.

    PMID: 28229243
  9. 9

    Long-term treatment with leuprorelin for spinal and bulbar muscular atrophy: natural history-controlled study.

    Hashizume A, Katsuno M, Suzuki K, et al.

    Journal of neurology, neurosurgery, and psychiatry 2017; (88(12)):1026-1032 doi:10.1136/jnnp-2017-316015.

    PMID: 28780536
  10. 10

    Swallowing markers in spinal and bulbar muscular atrophy.

    Banno H, Katsuno M, Suzuki K, et al.

    Annals of clinical and translational neurology 2017; (4(8)):534-543 doi:10.1002/acn3.425.

    PMID: 28812043
  11. 11

    Correlation between the CAG repeat size and electrophysiological findings in patients with spinal and bulbar muscular atrophy.

    Kim H, Lim YM, Lee EJ, et al.

    Muscle & nerve 2018; (57(4)):683-686 doi:10.1002/mus.25977.

    PMID: 28972672
  12. 12

    Quantitative Assessment of Swallowing Dysfunction in Patients with Spinal and Bulbar Muscular Atrophy.

    Hashizume A, Banno H, Katsuno M, et al.

    Internal medicine (Tokyo, Japan) 2017; (56(23)):3159-3165 doi:10.2169/internalmedicine.8799-16.

    PMID: 29021456
  13. 13

    Nonalcoholic fatty liver disease in spinal and bulbar muscular atrophy.

    Guber RD, Takyar V, Kokkinis A, et al.

    Neurology 2017; (89(24)):2481-2490 doi:10.1212/WNL.0000000000004748.

    PMID: 29142082
  14. 14

    X-linked spinal and bulbar muscular atrophy (Kennedy's disease): the first case described in the Brazilian Amazon.

    Alves CN, Braga TKK, Somensi DN, et al.

    Einstein (Sao Paulo, Brazil) 2018; (16(2)):eRC4011 doi:10.1590/S1679-45082018RC4011.

    PMID: 29898093
  15. 15

    Clinical manifestations and AR gene mutations in Kennedy's disease.

    Liu X, Zhu M, Li X, Tang J

    Functional & integrative genomics 2019; (19(3)):533-539 doi:10.1007/s10142-018-0651-7.

    PMID: 30612224
  16. 16

    Prevalence of metabolic syndrome and non-alcoholic fatty liver disease in a cohort of italian patients with spinal-bulbar muscular atrophy.

    Francini-Pesenti F, Querin G, Martini C, et al.

    Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology 2018; (37(3)):204-209.

    PMID: 30838350
  17. 17

    Nasometric Scores in spinal and bulbar muscular atrophy - Effects of palatal lift prosthesis on dysarthria and dysphagia.

    Tanaka S, Hashizume A, Hijikata Y, et al.

    Journal of the neurological sciences 2019; (407()):116503 doi:10.1016/j.jns.2019.116503.

    PMID: 31669728
  18. 18

    The French national protocol for Kennedy's disease (SBMA): consensus diagnostic and management recommendations.

    Pradat PF, Bernard E, Corcia P, et al.

    Orphanet journal of rare diseases 2020; (15(1)):90 doi:10.1186/s13023-020-01366-z.

    PMID: 32276665
  19. 19

    Metabolic alterations in spinal and bulbar muscular atrophy.

    Francini-Pesenti F, Vitturi N, Tresso S, Sorarù G

    Revue neurologique 2020; (176(10)):780-787 doi:10.1016/j.neurol.2020.03.020.

    PMID: 32631678
  20. 20

    Molecular pathogenesis of spinal bulbar muscular atrophy (Kennedy's disease) and avenues for treatment.

    Grunseich C, Fischbeck KH

    Current opinion in neurology 2020; (33(5)):629-634 doi:10.1097/WCO.0000000000000856.

    PMID: 32773451
  21. 21

    A Crucial Role for the Protein Quality Control System in Motor Neuron Diseases.

    Cristofani R, Crippa V, Cicardi ME, et al.

    Frontiers in aging neuroscience 2020; (12()):191 doi:10.3389/fnagi.2020.00191.

    PMID: 32792938
  22. 22

    Kennedy's disease: an under-recognized motor neuron disorder.

    Malek EG, Salameh JS, Makki A

    Acta neurologica Belgica 2020; (120(6)):1289-1295 doi:10.1007/s13760-020-01472-6.

    PMID: 32839928
  23. 23

    Clinical Phenotyping and Biomarkers in Spinal and Bulbar Muscular Atrophy.

    Millere E, Rots D, Glazere I, et al.

    Frontiers in neurology 2020; (11()):586610 doi:10.3389/fneur.2020.586610.

    PMID: 33551952
  24. 24

    Effect of leuprorelin in bulbar function of spinal and bulbar muscular atrophy patients: observational study for 1 year.

    Kang MG, Gwak DW, Cho HJ, et al.

    Journal of neurology 2021; (268(9)):3344-3351 doi:10.1007/s00415-021-10503-y.

    PMID: 33675422
  25. 25

    Exercise Intervention Leads to Functional Improvement in a Patient with Spinal and Bulbar Muscular Atrophy.

    Compo J, Joseph J, Shieh V, et al.

    Journal of rehabilitation medicine. Clinical communications 2020; (3()):1000041 doi:10.2340/20030711-1000041.

    PMID: 33884143
  26. 26

    Kennedy disease in two sisters with biallelic CAG expansions of the androgen receptor gene.

    Müller KI, Nilssen Ø, Nebuchenykh M, et al.

    Neuromuscular disorders : NMD 2022; (32(1)):75-79 doi:10.1016/j.nmd.2021.11.007.

    PMID: 34922802
  27. 27

    Nerve ultrasound detects abnormally small nerves in patients with spinal and bulbar muscular atrophy.

    Pelosi L, Ghosh A, Leadbetter R, et al.

    Muscle & nerve 2022; (65(5)):599-602 doi:10.1002/mus.27509.

    PMID: 35092036
  28. 28

    Castration-resistant prostate cancer diagnosed during leuprorelin treatment for spinal and bulbar muscular atrophy.

    Yanase A, Sugihara T, Akimoto T, et al.

    IJU case reports 2022; (5(4)):251-254 doi:10.1002/iju5.12447.

    PMID: 35795131
  29. 29

    SAFETY AND TOLERABILITY OF STRENGTH TRAINING IN SPINAL AND BULBAR MUSCULAR ATROPHY: A CASE REPORT.

    Shieh V, Zampieri C, Stout P, et al.

    Journal of rehabilitation medicine. Clinical communications 2022; (5()):2513 doi:10.2340/jrmcc.v5.2513.

    PMID: 36072267
  30. 30

    Reliable virtual clinical assessment in spino-bulbar muscular atrophy (SBMA).

    Fenu S, Tramacere I, De Giorgi F, Pareyson D

    Journal of neurology, neurosurgery, and psychiatry 2023; (94(2)):161 doi:10.1136/jnnp-2022-329616.

    PMID: 36137740
  31. 31

    Kennedy's disease presented with mastication fatigue combined with positive titin antibody: a case report.

    Ji G, Huang R, Zhou X, et al.

    BMC neurology 2022; (22(1)):425 doi:10.1186/s12883-022-02971-0.

    PMID: 36376797
  32. 32

    Troponin T in spinal and bulbar muscular atrophy (SBMA).

    Musso G, Blasi L, Mion MM, et al.

    Journal of the neurological sciences 2024; (456()):122816 doi:10.1016/j.jns.2023.122816.

    PMID: 38071852
  33. 33

    Case report: Klinefelter syndrome may protect against the development of spinal and bulbar muscular atrophy.

    Akanuma H, Kadowaki S, Kanai K

    Frontiers in neurology 2024; (15()):1340694 doi:10.3389/fneur.2024.1340694.

    PMID: 38405402
  34. 34

    A preliminary study on the effects of long-term robot suit exercise training on gait function and quality of life in patients with spinal and bulbar muscular atrophy.

    Hirayama T, Morioka H, Sugisawa T, et al.

    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2024; (128()):110778 doi:10.1016/j.jocn.2024.110778.

    PMID: 39168060
  35. 35

    Computed tomography-based radiological gynecomastia in SBMA as an independent differential diagnostic biomarker: a retrospective study.

    Kang M, Kim BJ, Nguyen B, Park JS

    Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology 2025; (46(2)):783-789 doi:10.1007/s10072-024-07820-1.

    PMID: 39467933
  36. 36

    Respiratory Trajectories and Correlation with Serum Biochemical Indices in Spinal and Bulbar Muscular Atrophy.

    Ginanneschi F, Bigliazzi C, Cimmino FA, et al.

    Brain sciences 2024; (14(11)) doi:10.3390/brainsci14111057.

    PMID: 39595820
  37. 37

    Different patterns of fasciculation in spinal and bulbar muscular atrophy and amyotrophic lateral sclerosis: a muscle ultrasonographic study.

    Nara T, Shibuya K, Ikeda S, et al.

    BMJ neurology open 2025; (7(1)):e001065 doi:10.1136/bmjno-2025-001065.

    PMID: 40297747
  38. 38

    Identifying Clinical Measures Related to Falls in Ambulatory Patients with Spinal and Bulbar Muscular Atrophy.

    Shrader JA, Niemic AC, Jiménez-Silva R, et al.

    Neurology international 2025; (17(6)) doi:10.3390/neurolint17060080.

    PMID: 40559319
  39. 39

    The spinal and bulbar muscular atrophy-health index: a disease-specific outcome measure.

    Alqahtani A, Weinstein J, Kokkinis A, et al.

    Amyotrophic lateral sclerosis & frontotemporal degeneration 2026; 1-9 doi:10.1080/21678421.2026.2620454.

    PMID: 41610298